59011-313 : 24 Hr Palladone 16 mg Extended Release Capsule

NDC:	59011-313
Labeler:	Purdue Pharma L.p.
Drug Name:	Palladone
Rev. Date:	Jan 4, 2006
CSA Schedule:	CII (US) [1]

^[1] Schedule II / IIN Controlled Substance: High potential for abuse which may lead to severe psychological or physical dependence. (i.e. Narcotics such as Dilaudid, Methadone, Demerol, Oxycodone, Percocet, Fentanyl, Morphine, Opium, Codeine, and Hydrocodone ... Schedule IIN stimulants include non-narcotic Amphetamines such as Dexedrine, Adderall, Desoxyn, Methylphenidate (Ritalin) ... Other Schedule II substances include Amobarbital, Glutethimide, and Pentobarbital. More Details: US Dept of Justice Controlled Substance Schedules.

Appearance:

Markings:	P-XL;16;mg
Shapes:	Capsule
Colors:	Pink
Size (mm):	18
Segments: *	1
* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines.

Active Ingredients:

• Hydromorphone

Inactive Ingredients:

• Ammonio Methacrylate Copolymer Type B
• Ethylcellulose
• Steryl Alcohol
• Gelatin
• Red Iron Oxide
• Synthetic Black Iron Oxide
• Titanium Dioxide

Related Products:

Based on records with the same trade name.

• 59011-312 24 Hr Palladone 12 mg Extended Release Capsule by Purdue Pharma L.p.
• 59011-314 24 Hr Palladone 24 mg Extended Release Capsule by Purdue Pharma L.p.
• 59011-315 24 Hr Palladone 32 mg Extended Release Capsule by Purdue Pharma L.p.

NDC QR Code

Scan the QR code below to easily reference this data in the future:



< Prev: 59011-312Next: 59011-314 >

Related Discussions: